This author has not yet filled in any details.
So far Eleanor Ndaiga has created 0 blog entries.
Newsletter Sign Up
Leave this field empty if you're human:
Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares
Appili Therapeutics Names Dr. Armand Balboni as Chief Executive Officer
Q3 2019 Share Price Performance
Triumvira Immunologics Announces Fast Track Designation for Its First TAC T-Cell Therapeutic Product Candidate: TAC01-CD19
MindBeacon Group announces Series A follow-on investment round led by Green Shield Canada has exceeded $18 million
Beyond the Bench
Biotech Black Box
Canada in Science
Clinical Trial Update
Health Innovation Nation
Monday Deal Reviews